Dana Jean Glass, ARNP

Dana Glass practices at Schweiger Dermatology Group in Lady Lake, Florida.

Dana Glass' NPI, 1083268940, was assigned on July 30, 2019. Dana Glass holds Florida license APRN11003478.

Dana Glass' primary practice is Schweiger Dermatology Group, at 1503 Buenos Aires Blvd, Lady Lake, FL 32159 in Lake County. The practice phone is (352) 365-6650.

Dana Glass' primary practice is Schweiger Dermatology Group in Lady Lake, Florida. The medical group on file is Schweiger Dermatology Group. Dmand AI also links Dana Glass to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dana Glass practices. Vendor and product names are available with a free account.

Nurse practitioner is Dana Glass' primary specialty in the NPI Registry, under taxonomy code 363L00000X. Dana Glass is licensed in Florida.

Dmand AI lists acne, acute skin infection, ankle or foot injury, benign or precancerous skin growths, contact dermatitis, eyelid inflammation, itchy rashes and scalp rash among the conditions Dana Glass treats.

CMS data shows 487 Medicare services from Dana Glass across 8 procedure codes in 2024, for 144 Medicare patients. Medicare paid $16,540 for them. Every service was in an office.

CMS counts 144 Medicare patients who saw Dana Glass in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dana Glass' median patient age at 67, with 56% women.

In 2024, Dana Glass wrote 614 Medicare Part D claims for 289 patients. 99% of them were for generic drugs. CMS names the drug for 537 of them, across 11 drugs with 11 or more claims each, at $8,554 in total drug cost.

Dana Glass accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 99 general payments to Dana Glass from 20 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 90% of the total. Janssen Pharmaceuticals, Inc paid the most, $554.